21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.89.A - Production of dietary supplements
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
63.10 - Services related to computing infrastructure, data processing, website management (hosting), and related activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 28,2 | 22,8 | 27,6 | 21,3 |
EBITDA | 30,6 | 25,7 | 30,6 | 19,2 |
Short time liabilities | 8,3 | 14,8 | 14,5 | -2,1 |
Equity capital | 62,5 | 40 | 62,1 | 55,2 |
Operating profit (EBIT) | 28,5 | 23,7 | 28,2 | 19,1 |
Assets | 75,4 | 59,9 | 88,1 | 47,1 |
Net profit (loss) | 22,9 | 18,3 | 22,1 | 20,8 |
Cash | 5,8 | 5,9 | 2,5 | -57,7 |
Liabilities and provisions for liabilities | 12,9 | 19,9 | 26 | 30,9 |
Net income from sale | 102,1 | 114,6 | 135,9 | 18,6 |
Working assets | 29 | 41,3 | 64,2 | 55,5 |
Depreciation | 2,1 | 2 | 2,4 | 21,4 |
% | % | % | p.p. | |
Profitability of capital | 36,6 | 45,7 | 35,6 | -10,1 |
Equity capital to total assets | 82,9 | 66,9 | 70,5 | 3,6 |
Gross profit margin | 27,6 | 19,9 | 20,3 | 0,4 |
EBITDA Margin | 30 | 22,4 | 22,5 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 47 | 39 | -8 |
Current financial liquidity indicator | 2.6762771606445312 | 2.5749337673187256 | 3.6197526454925537 | 1 |
Net dept to EBITDA | -0.07725629210472107 | -0.05052574723958969 | 0.15217678248882294 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane